RCM
MEDP icon

Raleigh Capital Management’s Medpace MEDP Stock Holding History

Raleigh Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34
Closed -$10.5K – 1098
2023
Q4 		$10.5K Buy
34
+1
+3% +$270 ﹤0.01% 577
2023
Q3 		$8.06K Buy
33
+5
+18% +$1.28K ﹤0.01% 587
2023
Q2 		$6.79K Buy
28
+9
+47% +$1.87K ﹤0.01% 569
2023
Q1 		$3.57K Buy
19
+4
+27% +$827 ﹤0.01% 683
2022
Q4 		$3.19K Buy
+15
New +$3K ﹤0.01% 620

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Raleigh Capital Management's MEDP Position: Q1 2024 in Review

Raleigh Capital Management sold out of Medpace (MEDP) in Q1 2024, closing a stake of 34 shares — an estimated $10.5K sold.

Raleigh Capital Management first reported a position in MEDP in Q4 2022 and held it in 5 quarters. The position peaked at $10.5K in Q4 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • Raleigh Capital Management reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 34 Medpace shares in Q1 2024, an estimated $10.5K.
  • Raleigh Capital Management first reported a position in Medpace in Q4 2022 and held it in 5 quarters.
  • Raleigh Capital Management's Medpace position peaked at $10.5K in Q4 2023.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.